Ultra‐short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients

Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study

(2019) Antonio Franco et al.   TRANSPLANT INTERNATIONAL

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

(2019) David Wyles et al.   JOURNAL OF HEPATOLOGY

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update

(2019) Elise J. Smolders et al.   CLINICAL PHARMACOKINETICS

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

(2019) Ann E. Woolley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience

(2019) Miklos Z. Molnar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients

(2018) Christine M. Durand et al.   ANNALS OF INTERNAL MEDICINE

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

(2018) Fred Poordad et al.   HEPATOLOGY

The removal of DAA restrictions in Europe – one step closer to eliminating HCV as a major public health threat

(2018) Alison D. Marshall et al.   JOURNAL OF HEPATOLOGY

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

(2018) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study

(2018) Charitha Gowda et al.   Open Forum Infectious Diseases

Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy

(2018) Gaurav Gupta et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients

(2018) Peter P. Reese et al.   ANNALS OF INTERNAL MEDICINE

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment

(2017) Fred Poordad et al.   HEPATOLOGY

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

(2017) Katja Deterding et al.   LANCET INFECTIOUS DISEASES

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

(2017) Marc Bourlière et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients

(2017) David S. Goldberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C

(2016) Polina German et al.   CLINICAL PHARMACOKINETICS

Postexposure prophylaxis after hepatitis C occupational exposure in the interferon-free era

(2016) Heather Y. Hughes et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients

(2016) Josh Levitsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR

(2015) Hector E. Nazario et al.   LIVER INTERNATIONAL

Transplanting Hepatitis C–Positive Kidneys

(2015) Peter P. Reese et al.   NEW ENGLAND JOURNAL OF MEDICINE

NK Cells, Innate Immunity and Hepatitis C Infection after Liver Transplantation

(2011) A. Nellore et al.   CLINICAL INFECTIOUS DISEASES

Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive Recipients

(2010) L. M. Kucirka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation

(2009) Nicolas C. Issa et al.   CLINICAL INFECTIOUS DISEASES

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE